Tayler et al. [82] demonstrated that 21% of pediatric DIPG are heterozygous for the mutated Activin A Receptor Type 1 (ACVR1) gene, which is also observed in patients with the connective tissue disorder Fibrodysplasia ossificans progressive (FOP). This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.